What is the Standard Biotools Inc. stock price forecast?

Standard Biotools Inc. is currently trading at $0.83. View real-time AI analysis on Alpha Lenz.

What is Standard Biotools Inc. insider trading activity?

View the latest insider trading data for Standard Biotools Inc. on Alpha Lenz.

What is Standard Biotools Inc.'s P/E ratio?

Standard Biotools Inc.'s P/E ratio is -4.2.

Standard Biotools Inc.

NASDAQ · LAB

$0.83-0.02(-2.15%)Pre-market

Ask about Standard Biotools Inc.'s future dividend policy...

Alpha Chat Insight

“Standard Biotools Inc. trades at a P/E of -4.2 (undervalued) with modest ROE of -16.7%.”

Ask for details →

Company Overview

Standard Biotools Inc. is a leading developer and provider of innovative life sciences tools and solutions. This company focuses on empowering researchers by delivering precision instruments and systems essential for high-throughput DNA sequencing, protein analysis, and molecular diagnostics. With a commitment to advancing healthcare and scientific discovery, Standard Biotools provides critical support to industries such as biotechnology, pharmaceuticals, and academic research institutions. Their cutting-edge platforms facilitate more effective and efficient data analysis, enabling breakthroughs in personalized medicine and disease understanding. Headquartered in the United States, Standard Biotools Inc. plays a vital role in the life sciences sector, frequently collaborating with research entities to propel forward the capabilities of modern biological technology. This company's contributions are crucial in addressing global health challenges and paving the way for future innovations in the scientific community.

CEODr. Michael Egholm Ph.D.

Websitehttps://www.standardbio.com

SectorHealthcare

IndustryMedical Devices

Employees814

Company Statistics

FY 2025

Profile

$317.40MMarket Cap

$85.33MRevenue

0.00Shares Out

814Employees

Margins

49.86%Gross

-80.57%EBITDA

-109.34%Operating

-113.33%Pre-Tax

-87.77%Net

Valuation

-4.24P/E

0.75P/B

3.72EV/Sales

-3.31EV/EBITDA

-3.84P/FCF

Growth (CAGR)

-4.49%Rev 3Yr

-9.19%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-12.69%ROA

-16.72%ROE

-16.38%ROIC

Financial Health

$120.86MCash & Cash Equivalents

$22.60MNet Debt

33.81%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Standard Biotools Inc. trades at a P/E of -4.2 (undervalued) with modest ROE of -16.7%.”

Ask for details →

Frequently Asked Questions

Standard Biotools Inc. (ticker: LAB) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 814 employees. Market cap is $317M.

The current price is $0.832 with a P/E ratio of -4.24x and P/B of 0.75x.

ROE is -16.72% and operating margin is -109.34%. Annual revenue is $85M.